Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Neoplasms、Lung Neoplasms、Pancreatic Neoplasms”

346 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 346 results

Not applicableLooking for participantsNCT04638751
What this trial is testing

ARGONAUT: Stool and Blood Sample Bank for Cancer Patients

Who this might be right for
Non-small Cell Lung CancerColorectal CancerTriple Negative Breast Cancer+1 more
Persephone Biosciences 5,000
Testing effectiveness (Phase 2)Looking for participantsNCT06224387
What this trial is testing

CTS2190 Phase I /II Clinical Study in Patients

Who this might be right for
Solid TumorsPancreatic CancerNon-small Cell Lung Cancer+1 more
CytosinLab Therapeutics Co., Ltd. 224
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Testing effectiveness (Phase 2)Ended earlyNCT05070247
What this trial is testing

TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerHepatocellular CancerMesothelioma+7 more
Takeda 61
Testing effectiveness (Phase 2)UnknownNCT05830097
What this trial is testing

Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Who this might be right for
Cancer, BreastCancer, LungCancer of Pancreas+2 more
Coherent Biopharma (Hefei) Co., Ltd. 260
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)Ended earlyNCT00739609
What this trial is testing

IDO Inhibitor Study for Relapsed or Refractory Solid Tumors

Who this might be right for
Breast CancerLung CancerMelanoma+2 more
NewLink Genetics Corporation 17
Early research (Phase 1)Study completedNCT04925284
What this trial is testing

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

Who this might be right for
Non Small Cell Lung CancerCervical CancerSCCHN+8 more
Exelixis 269
Early research (Phase 1)Looking for participantsNCT04389632
What this trial is testing

Sigvotatug Vedotin in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more
Seagen, a wholly owned subsidiary of Pfizer 1,006
Not applicableLooking for participantsNCT05248763
What this trial is testing

Taiwan Cancer Moonshot Project

Who this might be right for
Malignant Neoplasm of Body of Stomach in Situ
Academia Sinica, Taiwan 4,190
Testing effectiveness (Phase 2)WithdrawnNCT02713984
What this trial is testing

A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer

Who this might be right for
Breast CancerOvarian CancerLung Cancer+4 more
Zhi Yang
Early research (Phase 1)Looking for participantsNCT06242470
What this trial is testing

MGC026 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced CancerMetastatic Cancer+19 more
MacroGenics 250
Early research (Phase 1)Study completedNCT01041235
What this trial is testing

Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies

Who this might be right for
Solid TumorBreast CancerOvarian Cancer+2 more
Azaya Therapeutics, Inc. 29
Early research (Phase 1)Study completedNCT02639026
What this trial is testing

Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers

Who this might be right for
MetastaticMelanomaNon Small Cell Lung Cancer (NSCLC)+2 more
Abramson Cancer Center at Penn Medicine 53
Testing effectiveness (Phase 2)Looking for participantsNCT07410676
What this trial is testing

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

Who this might be right for
CancerSarcomaLeukaemia+12 more
Essen Biotech 83
Not applicableWithdrawnNCT04584775
What this trial is testing

Implementing Acupuncture and Chinese Herbal Medicine Into Palliative Care

Who this might be right for
Advanced CancerLung CancerBreast Cancer+5 more
Medical University of Graz
Not applicableLooking for participantsNCT07331532
What this trial is testing

68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors

Who this might be right for
Breast Neoplasms、Lung Neoplasms、Pancreatic Neoplasms
Peking University First Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT06239194
What this trial is testing

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Who this might be right for
Biliary Tract CancerBreast CancerCervical Cancer+13 more
ModeX Therapeutics, An OPKO Health Company 115
Testing effectiveness (Phase 2)Ended earlyNCT04504916
What this trial is testing

Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002)

Who this might be right for
Triple-negative Breast CancerNon-squamous Non-small-cell Lung CancerNSCLC+12 more
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 102
Early research (Phase 1)Looking for participantsNCT06673329
What this trial is testing

Brodalumab in the Treatment of Immune-Related Adverse Events

Who this might be right for
Breast CancerEsophageal CancerKidney Cancer+15 more
Brian Henick, MD 11
Load More Results